Eucrates Biomedical Acquisition Corp (EUCR)

Etorro trading 970x250

About Eucrates Biomedical Acquisition Corp

Eucrates Biomedical Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York. Address: 250 West 55Th Street, New York, NY, United States, 10019

Eucrates Biomedical Acquisition Corp News and around…

Latest news about Eucrates Biomedical Acquisition Corp (EUCR) common stock and company :

Eucrates Biomedical Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report
01 Jun, 2021 Yahoo! Finance

Eucrates Biomedical Acquisition Corp. (Nasdaq: EUCR) (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced that it received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the "Form 10-Q") with the Securities and Exchange Commission ("SEC"). The Notice has no immediate effect on the listing or trading of the Company's securities on the Nasdaq Capital Market.

Here's What Eucrates Biomedical Acquisition Corp.'s (NASDAQ:EUCR) Shareholder Ownership Structure Looks Like
11 May, 2021 Yahoo! Finance

If you want to know who really controls Eucrates Biomedical Acquisition Corp. ( NASDAQ:EUCR ), then you'll have to look...

Eucrates Biomedical Acquisition Corp (EUCR) is a NASDAQ Common Stock listed in , ,

970x250